China NMPA Product Recall - femoral head

Smith & Nephew, Inc. initiated a voluntary Class II recall for its femoral head device following the discovery of critical packaging errors in some products. This action was publicly reported by Smith & Nephew Medical Products International Trading (Shanghai) Co., Ltd., and announced by the National Medical Products Administration (NMPA) on May 8, 2024. The primary issue identified was a packaging discrepancy, which can potentially affect the device's integrity or proper identification. The document does not specify any inspection dates, rather it details a company-initiated recall. Operating under the regulatory framework of the NMPA in China, a Class II recall indicates that the product's use may lead to temporary or medically reversible adverse health consequences, or that serious adverse health consequences are remote. Consequently, Smith & Nephew, Inc. is required to remove all affected femoral head devices from the market. Comprehensive details, including specific models, specifications, and batch numbers of the impacted products, are contained within a separate Medical Device Recall Event Report Form submitted to the NMPA, which was not provided in the public announcement. This recall highlights the imperative for rigorous quality control throughout the medical device supply chain.